GI Dysmotility Symptoms Are Not Associated With Increased L-Dopa Requirements in Parkinson's Disease Patients

被引：0
|
作者：
Chang, Jocelyn [1 ]
Gadi, Sanjay [2 ]
Kuo, Braden [3 ]
Pasricha, Trisha S. [3 ]
机构：
[1] Tufts Univ, Sch Med, Boston, MA 02111 USA
[2] Harvard Med Sch, Boston, MA 02115 USA
[3] Massachusetts Gen Hosp, Boston, MA 02114 USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2022年 / 117卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
S1548
引用
收藏
页码：S1107 / S1108
页数：2
相关论文
共 50 条
  • [41] Wearing-off symptoms in Parkinson's disease patients on L-DOPA in the Czech Republic - the results of EWO study
    Bares, M.
    Rektorova, I.
    Jech, R.
    Farnikova, K.
    Roth, J.
    Ruzicka, E.
    Kanovsky, P.
    Rektor, I.
    Pavlik, T.
    Chroust, K.
    Uhlirova, L.
    Vydlak, J.
    PARKINSONISM & RELATED DISORDERS, 2009, 15 : S121 - S121
  • [42] Safety and tolerability profile of preladenant as an adjunct to L-dopa in patients with Parkinson's disease
    Pourcher, E.
    Micheli, F.
    Mok, V.
    Onofrj, M.
    Hauser, R. A.
    Huyck, S.
    Wolski, K.
    Cantillon, M.
    MOVEMENT DISORDERS, 2009, 24 : S274 - S274
  • [43] Dynamics of Cognitive Impairments in Patients with Parkinson’s Disease Receiving L-DOPA Treatment
    Ismailova S.B.
    Prokopenko S.V.
    Pokhabov D.V.
    Mosaleva E.I.
    Alekseenko P.V.
    Zhumzhanov I.M.
    Neuroscience and Behavioral Physiology, 2022, 52 (3) : 368 - 372
  • [44] Reduced L-dopa absorption and increased clinical fluctuations in Helicobacter pylori-infected Parkinson's disease patients
    Pierantozzi, M
    Pietroiusti, A
    Sancesario, G
    Lunardi, G
    Fedele, E
    Giacomini, P
    Frasca, S
    Galante, A
    Marciani, MG
    Stanzione, P
    NEUROLOGICAL SCIENCES, 2001, 22 (01) : 89 - 91
  • [45] Effects of helicobacter pylori eradication on l-dopa absorption in Parkinson's disease patients
    Brusa, L
    Pietroiusti, A
    Pierantozzi, M
    Galati, S
    Moschella, V
    Sancesario, G
    Lunardi, G
    Fedele, E
    Miguel, MJG
    Luzzi, I
    Bergamaschi, A
    Magrini, A
    Stanzione, P
    Galante, A
    PROCEEDINGS OF THE 7TH CONGRESS OF THE EUROPEAN SOCIETY FOR CLINICAL NEUROPHARMACOLOGY, 2004, : 67 - 71
  • [46] Reduced L-dopa absorption and increased clinical fluctuations in Helicobacter pylori-infected Parkinson's disease patients
    M. Pierantozzi
    A. Pietroiusti
    G. Sancesario
    G. Lunardi
    E. Fedele
    P. Giacomini
    S. Frasca
    A. Galante
    M. G. Marciani
    P. Stanzione
    Neurological Sciences, 2001, 22 : 89 - 91
  • [47] Bound, free, and total l-dopa measurement in plasma of Parkinson's disease patients
    Mueller, Thomas
    Thiede, Hans Michael
    JOURNAL OF NEURAL TRANSMISSION, 2019, 126 (11) : 1417 - 1420
  • [48] Effective threshold concentration and L-dopa dose of Japanese patients with Parkinson's disease
    Murata, M.
    Teraoka, Y.
    Aoki, Y.
    Inoue, C.
    Saito, Y.
    Endo, F.
    Takemura, A.
    Okamoto, T.
    Lin, Y.
    Yamamoto, T.
    Tsukamoto, T.
    Kuno, S.
    Kanazawa, I.
    MOVEMENT DISORDERS, 2006, 21 : S645 - S645
  • [49] Cabergoline scavenges peroxynitrite enhanced by L-DOPA therapy in patients with Parkinson's disease
    Isobe, C.
    Abe, T.
    Kikuchi, T.
    Murata, T.
    Sato, C.
    Hattori, N.
    Terayama, Y.
    MOVEMENT DISORDERS, 2006, 21 : S474 - S475
  • [50] Bound, free, and total l-dopa measurement in plasma of Parkinson’s disease patients
    Thomas Müller
    Hans Michael Thiede
    Journal of Neural Transmission, 2019, 126 : 1417 - 1420
12345